82268-15-3

Basic information

• Product Name: 3-methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazolidine
• Synonyms: 3-methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazolidine;(R)-2-(2,2-DiMethyl-1,3-dioxolan-4-yl)propan-2-ol
• CAS NO: 82268-15-3
• Molecular Formula: C₈H₁₆O₃
• Molecular Weight: 157.2135
• Mol File: 82268-15-3.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 238.699°C at 760 mmHg
• Flash Point: 90.324°C
• Appearance: /
• Density: 1.047g/cm³
• Vapor Pressure: 0.042mmHg at 25°C
• Refractive Index: 1.472
• PKA: 14.34±0.29(Predicted)
• CAS DataBase Reference: 3-methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazolidine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazolidine(82268-15-3)
• EPA Substance Registry System: 3-methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazolidine(82268-15-3)

Safety Data

• Hazardous Substances Data: 82268-15-3(Hazardous Substances Data)

Usage

General Description

3-Methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazolidine is a chemical compound with the molecular formula C8H14N4O. It is a member of the oxadiazolidine class of compounds, which are known for their potential pharmaceutical and medicinal applications. This specific compound contains a 1,2,4-oxadiazolidine ring and a pyrrolidine ring, both of which are important structural elements in many biologically active molecules. The presence of the methyl group at the 3-position and the pyrrolidin-3-yl group at the 5-position further enhances the compound's potential biological activity. Research on 3-Methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazolidine and related compounds is ongoing to explore their potential as pharmaceutical agents, particularly in the treatment of various diseases and disorders.

InChI:InChI=1/C7H15N3O/c1-5-9-7(11-10-5)6-2-3-8-4-6/h5-10H,2-4H2,1H3

Upstream product

• 52373-72-5 methyl (R)-2,2-dimethyl-1,3-dioxolane-4-carboxylate 
• 110548-95-3 evoxine 
• 77-76-9 2,2-dimethoxy-propane 
• 917-54-4 methyllithium 
• 75-16-1 methylmagnesium bromide 
• 102563-44-0 (R)-2,2-Dimethyl-4-dimethylaminocarbonyl-1,3-dioxolane 
• 917-64-6 methyl magnesium iodide 
• 61821-86-1 (R)-2,2-dimethyl-1,3-dioxolan-4-yl methyl ketone 

Downstream Products

• 77522-15-7 (2R)-2,3-dihydroxy-3-methylbutan-1-yl p-toluenesulfonate 

Relevant articles and documents

Synthesis, structure and stereochemistry of quinoline alkaloids from Choisya ternata

A range of seventeen quinoline alkaloids, involving several types of oxidations during their biosynthetic pathways, have been isolated from leaves of Choisya ternata. In addition to the nine known quinoline alkaloids, eight new members of the furoquinoline family, derived mainly from prenylation at C-5 (including two novel hydroperoxides), have been identified. The absolute configurations and enantiopurity values of all chiral quinoline alkaloids have been determined. One of the isolated alkaloids, 7-isopentenyloxy-γ- fagarine, has been used as a precursor for the chemical asymmetric synthesis of the enantiopure alkaloids: evoxine, anhydroevoxine and evodine. The possible roles of oxygenase and other oxygen-atom-transfer enzymes, in the biosynthetic pathways of the C. ternata alkaloids, have been discussed. This journal is The Royal Society of Chemistry.

PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS

A compound of formula (1), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders.

Process for the preparation of cholesterol derivatives and novel intermediates therefor

The invention is concerned with a process for the preparation of 1 hydrogen or hydroxy cholesterol derivatives and intermediates therefor. The compounds of the present invention are useful as intermediates in the preparation of 24,25-dihydroxy and 1α, 24,25-trihydroxycholecalciferol.